Drug Discovery Technologies Market | Business Growth, Development Factors, Current and Future Trends till 2029

 Created for forward-thinking professionals, this report equips teams with the insights needed to compete effectively in the drug discovery technologies space.

 

 Drug Discovery Technologies Market Analysis & Forecast: 2025–2029
 The drug discovery technologies market size has grown rapidly in recent years. It will grow from $72.99 billion in 2024 to $80.76 billion in 2025 at a compound annual growth rate (CAGR) of 10.6%. The growth in the historic period can be attributed to growth in genomic and proteomic research, increased understanding of molecular biology, expansion of combinatorial chemistry, adoption of bioinformatics and computational approaches, rise of targeted therapies.
 
 The drug discovery technologies market size is expected to see rapid growth in the next few years. It will grow to $124.89 billion in 2029 at a compound annual growth rate (CAGR) of 11.5%. The growth in the forecast period can be attributed to adoption of crispr for gene editing, expansion of precision medicine approaches, application of omics technologies in drug development, utilization of quantum computing in drug discovery, rise of patient-derived xenograft (pdx) models. Major trends in the forecast period include advancements in high-throughput screening, development of automated laboratory equipment, collaboration between academic and industry research, technological advances in imaging and microscopy, integration of artificial intelligence in drug discovery, 3d cell culture technologies, adoption of machine learning in drug design, collaboration between pharma companies and tech startups, integration of blockchain for data security.
 
 Get your free sample today:
 https://www.thebusinessresearchcompany.com/sample.aspx?id=12715&type=smp
 
 What Are The Factors Driving The Drug Discovery Technologies Market?
 The rising prevalence of acute and chronic diseases is expected to propel the drug discovery technologies market going forward. Chronic diseases last one year or more and require ongoing medical attention. Innovation in drug discovery technologies and drug development has brought many new treatments for chronic diseases. Integrating new and powerful emerging technologies, including digital health tools, AI, and machine learning, throughout the drug R&D process offers opportunities to address critical barriers and streamline clinical trials for prevalent chronic diseases. For instance, in May 2023, according to The United Nations (UN), a US-based intergovernmental organization to promote international cooperation and maintain international peace and security, Chronic diseases were responsible for seven out of 10 deaths in the US, killing more than 1.7 million Americans annually. Therefore, the rising prevalence of acute and chronic diseases will drive the drug discovery technologies market.
 
 What Segments Are Covered In The Drug Discovery Technologies Market Report?
 The drug discovery technologiesmarket covered in this report is segmented — 
 
 1) By Technology: High Throughput Screening; Genomics; Nanotechnology; Bioinformatics; Combinational Chemistry; Pharmacogenomics; Biochips; Bioanalytical Instruments; Ribonucleic Acid Interface (RNAI)
 2) By Drug Type: Small Molecule Drugs; Biologic Drugs
 3) By Disease Application: Cancer Diseases; Immunological Diseases; Neurological Diseases; Cardiovascular Diseases; Other Disease Applications
 4) By End-User: Pharmaceutical Companies; Biopharmaceutical Companies; Biotechnology Companies; Research Institutes; Other End-Users
 
 Subsegments:
 1) By High Throughput Screening: Automated Screening Systems; Assay Development 
 2) By Genomics: DNA Sequencing; Genomic Data Analysis 
 3) By Nanotechnology: Nanoparticle-Based Drug Delivery; Nanomaterials For Drug Formulation 
 4) By Bioinformatics: Data Analysis Tools; Computational Biology Software 
 5) By Combinational Chemistry: Library Synthesis Techniques; Screening Methods 
 6) By Pharmacogenomics: Genetic Testing Platforms; Personalized Medicine Applications 
 7) By Biochips: Microarrays; Lab-On-A-Chip Technologies 
 8) By Bioanalytical Instruments: Mass Spectrometry; Chromatography Systems 
 9) By Ribonucleic Acid Interface (RNAI): RNA Interference Technologies; Therapeutic RNA Applications 
 
 What Are The Main Trends, Positively Impacting The Growth Of Drug Discovery Technologies Market?
 The invention of advanced technologies is a key trend in the drug discovery technologies market. Major companies operating in the drug discovery technologies market are launching advanced technologies to sustain their position in the market. For instance, in May 2023, Google LLC, a US-based technology company, launched Target and Lead Identification Suite, an AI-based tool to accelerate drug discovery. It is made to assist businesses in foreseeing and comprehending protein structure, a crucial aspect of drug research. The Suite will assist researchers in ingesting, storing, analyzing, and sharing vast volumes of genetic data. The new suites will help businesses save statistically significant amounts of time and money through the drug development process. They will contribute to resolving a long-standing problem in the biopharmaceutical sector.
 
 Which Are The Major Players Operating In The Global Drug Discovery Technologies Market?
 Major companies operating in the drug discovery technologies market include F. Hoffmann-La Roche AG, Novartis AG, Thermo Fisher Scientific Inc., AstraZeneca plc., Merck KGaA, GE HealthCare Technologies Inc., Agilent Technologies Inc., Dassault Systemes SA, Charles River Laboratories International Inc., Bio-Rad Laboratories Inc., Evotec SE, Curia Global Inc., Aragen Life Sciences Private Limited, Luminex Corporation, BioXcel Therapeutics Inc., Certara Inc., Schrödinger Inc., Sygnature Discovery Ltd., Recursion Pharmaceuticals Inc., InSilico Medicine Inc., ChemAxon Ltd., Enamine Ltd., BenevolentAI Limited, OpenEye Scientific Software Inc., Collaborative Drug Discovery Inc., Pharmacelera S.L., Gyros Protein Technologies AB, Optibrium Ltd., Cresset Group, Relay Therapeutics Inc. 
 
 View the full drug discovery technologies market report here:
 https://www.thebusinessresearchcompany.com/report/drug-discovery-technologies-global-market-report
 
 Drug Discovery Technologies Market Regional Insights:
 North America was the largest region in the drug discovery technologies market in 2024. The regions covered in the drug discovery technologies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
 
 Contact Us:
 
 The Business Research Company 
 
 https://thebusinessresearchcompany.com/ 
 
 Americas +1 310–496–7795
 Asia +44 7882 955267 & +91 8897263534
 Europe +44 7882 955267 
 
 Email: info@tbrc.info 
 
 
 Follow Us On:
 
 LinkedIn: https://in.linkedin.com/company/the-business-research-company